Bayer Schering Pharma AG et al v. Lupin Ltd et al

Filing 84

ORDER granting #82 Motion to Seal Declaration of Sundeep K. Addy. Signed by Magistrate Judge Robert J. Johnston on 7/21/11. (Copies have been distributed pursuant to the NEF - ECS)

1
2
3
4

Michael J. McCue (Nevada Bar #6055)
Jonathan W. Fountain (Nevada Bar #10351)
LEWIS AND ROCA LLP
3993 Howard Hughes Parkway, Suite 600
Las Vegas, Nevada 89169
[phone] (phone)
[phone] (facsimile)
[e-mail]

5
6
7
8
9
10
11
12
13
14
15
16
17
18

Of Counsel:
Peter B. Bensinger, Jr.
Adam K. Mortara
Sundeep K. (Rob) Addy
Matthew R. Ford
BARTLIT BECK HERMAN PALENCHAR & SCOTT LLP
54 West Hubbard Street
Chicago, Illinois 60654
[phone] (phone)
[phone] (facsimile)
[e-mail]
[e-mail]
[e-mail]
[e-mail]
Paul J. Skiermont
SKIERMONT PUCKETT LLP
2200 Ross Ave., Suite 4301W
Dallas, Texas 75201
[phone] (phone)
[phone] (facsimile)
[e-mail]
Attorneys for Plaintiffs Bayer Schering Pharma AG
and Bayer HealthCare Pharmaceuticals Inc.

UNITED STATES DISTRICT COURT
DISTRICT OF NEVADA

19
20
21
22

Bayer Schering Pharma AG &
Bayer HealthCare Pharmaceuticals Inc.,
Plaintiffs,

23
v.

24
25
26

Lupin Limited & Lupin Pharmaceuticals, Inc.
Defendants.

Case No. 2:10-cv-01166-KJD-RJJ
Motion For Leave To File The Declaration
Of Sundeep K. Addy In Support of Bayer’s
Memorandum Of Points And Authorities
In Opposition To The Lupin Defendants’
Motion For Summary Judgment That The
Claims Of United States Reissue Patent No.
37,564 Are Invalid As Obvious Under Seal

1

Pursuant to the Protective Order in the above-captioned case (Doc. 17), Plaintiffs Bayer

2

Schering Pharma AG and Bayer HealthCare Pharmaceuticals Inc. (collectively, “Bayer”) seeks

3

leave to file under seal certain exhibits attached to the concurrently-filed The Declaration Of

4

Sundeep K. Addy In Support of Bayer’s Memorandum Of Points And Authorities In Opposition

5

To The Lupin Defendants’ Motion For Summary Judgment That The Claims Of United States

6

Reissue Patent No. 37,564 Are Invalid As Obvious (“Addy Declaration”). In support of this

7

Motion, Bayer states as follows:

8
9

1.

The Protective Order in this case permits each party to designate certain

information produced during discovery as “CONFIDENTIAL” if the designating party reasonably

10

believes that the information should be protected from public disclosure. (Doc. 17 at 2-3.) The

11

Protective Order further specifies that the parties may file documents under seal under an order of

12

this Court for cause shown. (Id. at 13).

13
14
15
16
17

2.

Certain exhibits attached to the Addy Declaration consist of documents that the

parties have designated as “CONFIDENTIAL” in this case.
3.

Bayer therefore seeks leave of the Court to file the Addy Declaration and

accompanying exhibits under seal.
4.

In addition, Bayer has concurrently filed a public version of the Addy Declaration

18

which redacts only those exhibits that need to remain confidential under the protective order.

19

Specifically, Bayer seeks leave to file under seal Exhibits 1, 5, 7, 12, and 22-28. The remainder of

20

the Exhibits to the Addy Declaration will not remain under seal.

21
22
23
24
25
26
1

1

Respectfully Submitted: July 15, 2011

2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

/s/ Michael J. McCue
Michael J. McCue (Nevada Bar #6055)
Jonathan W. Fountain (Nevada Bar #10351)
LEWIS AND ROCA LLP
3993 Howard Hughes Parkway, Suite 600
Las Vegas, Nevada 89169
[phone] (phone)
[phone] (facsimile)
[e-mail]
Of Counsel:
Peter B. Bensinger, Jr.
Adam K. Mortara
Sundeep K. (Rob) Addy
Matthew R. Ford
BARTLIT BECK HERMAN PALENCHAR & SCOTT LLP
54 West Hubbard Street
Chicago, Illinois 60654
[phone] (phone)
[phone] (facsimile)
[e-mail]
[e-mail]
[e-mail]
[e-mail]
Paul J. Skiermont
SKIERMONT PUCKETT LLP
2200 Ross Ave., Suite 4301W
Dallas, Texas 75201
[phone] (phone)
[phone] (facsimile)
[e-mail]
Attorneys for Plaintiffs Bayer Schering Pharma AG and
Bayer HealthCare Pharmaceuticals Inc.
IT IS SO ORDERED.
_________________________________
U.S. MAGISTRATE JUDGE
DATE: JULY 21, 2011

23
24
25
26
2